Sreenivasulu Chintala, PhD
Associate Research Professor of Pediatrics
- Address
-
R4 335
PADB
IN
Indianapolis, IN - PubMed:
| Year | Degree | Institution |
|---|---|---|
| 1995 | PhD | Sri Krishnadevaraya University |
| 1992 | BED | Annamalai University |
| 1988 | MS | Sri Krishnadevaraya University |
| 1986 | BSC | Sri Krishnadevaraya University |
EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming.
Adelaiye-Ogala R; Budka J; Damayanti NP; Arrington J; Ferris M; Hsu CC; Chintala S; Orillion A; Miles KM; Shen L; Elbanna M; Ciamporcero E; Arisa S; Pettazzoni P; Draetta GF; Seshadri M; Hancock B; Radovich M; Kota J; Buck M; Keilhack H; McCarthy BP; Persohn SA; Territo PR; Zang Y; Irudayaraj J; Tao WA; Hollenhorst P; Pili R; Cancer research 2017 Oct 4
Adelaiye-Ogala R; Budka J; Damayanti NP; Arrington J; Ferris M; Hsu CC; Chintala S; Orillion A; Miles KM; Shen L; Elbanna M; Ciamporcero E; Arisa S; Pettazzoni P; Draetta GF; Seshadri M; Hancock B; Radovich M; Kota J; Buck M; Keilhack H; McCarthy BP; Persohn SA; Territo PR; Zang Y; Irudayaraj J; Tao WA; Hollenhorst P; Pili R; Cancer research 2017 Oct 4
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.
Orillion A; Hashimoto A; Damayanti N; Shen L; Adelaiye-Ogala R; Arisa S; Chintala S; Ordentlich P; Kao C; Elzey B; Gabrilovich D; Pili R; Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul 11
Orillion A; Hashimoto A; Damayanti N; Shen L; Adelaiye-Ogala R; Arisa S; Chintala S; Ordentlich P; Kao C; Elzey B; Gabrilovich D; Pili R; Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul 11
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.
Pili R; Liu G; Chintala S; Verheul H; Rehman S; Attwood K; Lodge MA; Wahl R; Martin JI; Miles KM; Paesante S; Adelaiye R; Godoy A; King S; Zwiebel J; Carducci MA; British journal of cancer 2017 Feb 21
Pili R; Liu G; Chintala S; Verheul H; Rehman S; Attwood K; Lodge MA; Wahl R; Martin JI; Miles KM; Paesante S; Adelaiye R; Godoy A; King S; Zwiebel J; Carducci MA; British journal of cancer 2017 Feb 21
Genomic profiling of collecting duct renal carcinoma.
Chintala S; Pili R; Aging 2016 Oct 26
Chintala S; Pili R; Aging 2016 Oct 26
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
Wei L; Chintala S; Ciamporcero E; Ramakrishnan S; Elbanna M; Wang J; Hu Q; Glenn ST; Murakami M; Liu L; Gomez EC; Sun Y; Conroy J; Miles KM; Malathi K; Ramaiah S; Anbarasu A; Woloszynska-Read A; Johnson CS; Conroy J; Liu S; Morrison CD; Pili R; Oncotarget 2016 Nov 22
Wei L; Chintala S; Ciamporcero E; Ramakrishnan S; Elbanna M; Wang J; Hu Q; Glenn ST; Murakami M; Liu L; Gomez EC; Sun Y; Conroy J; Miles KM; Malathi K; Ramaiah S; Anbarasu A; Woloszynska-Read A; Johnson CS; Conroy J; Liu S; Morrison CD; Pili R; Oncotarget 2016 Nov 22
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
Wang J; Papanicolau-Sengos A; Chintala S; Wei L; Liu B; Hu Q; Miles KM; Conroy JM; Glenn ST; Costantini M; Magi-Galluzzi C; Signoretti S; Choueiri T; Gallucci M; Sentinelli S; Fazio VM; Poeta ML; Liu S; Morrison C; Pili R; Oncotarget 2016 May 24
Wang J; Papanicolau-Sengos A; Chintala S; Wei L; Liu B; Hu Q; Miles KM; Conroy JM; Glenn ST; Costantini M; Magi-Galluzzi C; Signoretti S; Choueiri T; Gallucci M; Sentinelli S; Fazio VM; Poeta ML; Liu S; Morrison C; Pili R; Oncotarget 2016 May 24
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.
Ramakrishnan S; Ku S; Ciamporcero E; Miles KM; Attwood K; Chintala S; Shen L; Ellis L; Sotomayor P; Swetzig W; Huang R; Conroy D; Orillion A; Das G; Pili R; BMC cancer 2016 Aug 9
Ramakrishnan S; Ku S; Ciamporcero E; Miles KM; Attwood K; Chintala S; Shen L; Ellis L; Sotomayor P; Swetzig W; Huang R; Conroy D; Orillion A; Das G; Pili R; BMC cancer 2016 Aug 9
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
Ciamporcero E; Shen H; Ramakrishnan S; Yu Ku S; Chintala S; Shen L; Adelaiye R; Miles KM; Ullio C; Pizzimenti S; Daga M; Azabdaftari G; Attwood K; Johnson C; Zhang J; Barrera G; Pili R; Oncogene 2015 Jun 29
Ciamporcero E; Shen H; Ramakrishnan S; Yu Ku S; Chintala S; Shen L; Adelaiye R; Miles KM; Ullio C; Pizzimenti S; Daga M; Azabdaftari G; Attwood K; Johnson C; Zhang J; Barrera G; Pili R; Oncogene 2015 Jun 29
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.